Immunosuppression Individualization
Immunosuppression Individualization is a clinical decision-making framework that distinguishes itself from standardized immunosuppressive protocols by systematically tailoring drug selection, dosing, and duration to individual patient characteristics, immune risk profiles, and longitudinal response monitoring to optimize graft outcomes while minimizing toxicity.
25
Publications
726
Citations
152
Authors
67
Institutions
Publications per year
2017–2026
7
Variants
Individualized ImmunosuppressionPersonalized Immunosuppression
25
Renal Transplant in HIV-Positive Patients
Jayme E. Locke · Archives of Surgery · 2009 · 64 citations
Medicine, Nephrology, Surgery +17
Elizabeth F. Krakow, Michael Hemmer, Tao Wang et al. · American Journal of Epidemiology · 2017 · 42 citations · Full text
1–5 of 25
152
2
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 152
67

Johns Hopkins University
Baltimore, United States
2 h-index
2 publications
99 citations

Karolinska Institutet
Stockholm, Sweden
1 h-index
1 publications
42 citations

Alberta Children's Hospital
Calgary, Canada
1 h-index
1 publications
13 citations

University of British Columbia
Vancouver, Canada
1 h-index
1 publications
13 citations

Université de Rouen Normandie
Rouen, France
1 h-index
1 publications
19 citations

Universitat Autònoma de Barcelona
Cerdanyola del Vallès, Spain
1 h-index
3 publications
42 citations

Hospital for Special Surgery
New York, United States
1 h-index
1 publications
20 citations

Yeshiva University
New York, United States
1 h-index
5 publications
115 citations
1–8 of 67
3 publications · 112 citations
3
h-index
3 publications · 104 citations
3
h-index
1 publications · 14 citations
1
h-index
1 publications · 35 citations
1
h-index
1 publications · 13 citations
1
h-index
1–5